These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8201588)

  • 1. 1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.
    Elliott JD; Lago MA; Cousins RD; Gao A; Leber JD; Erhard KF; Nambi P; Elshourbagy NA; Kumar C; Lee JA
    J Med Chem; 1994 May; 37(11):1553-7. PubMed ID: 8201588
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysine 182 of endothelin B receptor modulates agonist selectivity and antagonist affinity: evidence for the overlap of peptide and non-peptide ligand binding sites.
    Lee JA; Brinkmann JA; Longton ED; Peishoff CE; Lago MA; Leber JD; Cousins RD; Gao A; Stadel JM; Kumar CS
    Biochemistry; 1994 Dec; 33(48):14543-9. PubMed ID: 7981216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discovery of endothelin and its significance].
    Goto K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():575-83. PubMed ID: 15506451
    [No Abstract]   [Full Text] [Related]  

  • 4. Design, syntheses, and structure-activity relationships of indan derivatives as endothelin antagonists; new lead generation of non-peptidic antagonist from peptidic leads.
    Morimoto H; Fukushima C; Yamauchi R; Hosino T; Kikkawa K; Yasuda K; Yamada K
    Bioorg Med Chem; 2001 Feb; 9(2):255-68. PubMed ID: 11249118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.
    Buchan KW; Alldus C; Christodoulou C; Clark KL; Dykes CW; Sumner MJ; Wallace DM; White DG; Watts IS
    Br J Pharmacol; 1994 Aug; 112(4):1251-7. PubMed ID: 7952888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of endothelin B receptor selective antagonist RES-701-1 determined by 1H NMR spectroscopy.
    Katahira R; Shibata K; Yamasaki M; Matsuda Y; Yoshida M
    Bioorg Med Chem; 1995 Sep; 3(9):1273-80. PubMed ID: 8564420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Agonists and antagonists to endothelin receptors].
    Ihara M; Yano M
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1827-40. PubMed ID: 8210428
    [No Abstract]   [Full Text] [Related]  

  • 8. Enrasentan, an antagonist of endothelin receptors.
    Cosenzi A
    Cardiovasc Drug Rev; 2003; 21(1):1-16. PubMed ID: 12595914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the structures of the endothelin A receptor antagonists BQ123 and N-methyl leucine BQ123 with the crystal structure of the C-terminal tail of endothelin-1.
    Peishoff CE; Janes RW; Wallace BA
    FEBS Lett; 1995 Nov; 374(3):379-83. PubMed ID: 7589575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death.
    Raschack M; Unger L; Riechers H; Klinge D
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S397-9. PubMed ID: 8587425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of C-terminal endothelin hexapeptide antagonists.
    Doherty AM; Cody WL; DePue PL; He JX; Waite LA; Leonard DM; Leitz NL; Dudley DT; Rapundalo ST; Hingorani GP
    J Med Chem; 1993 Sep; 36(18):2585-94. PubMed ID: 8410970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of endothelins.
    Masaki T
    Cardiovasc Res; 1998 Sep; 39(3):530-3. PubMed ID: 9861293
    [No Abstract]   [Full Text] [Related]  

  • 13. Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies.
    Benigni A
    Curr Opin Nephrol Hypertens; 1995 Jul; 4(4):349-53. PubMed ID: 7552102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
    Rubanyi GM; Polokoff MA
    Pharmacol Rev; 1994 Sep; 46(3):325-415. PubMed ID: 7831383
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modelling of the structures of endothelin antagonists. Identification of a possible structural determinant for ET-A receptor binding.
    Satoh T; Barlow D
    FEBS Lett; 1992 Sep; 310(1):83-7. PubMed ID: 1326444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptors: receptor classification, novel receptor antagonists, and potential therapeutic targets.
    Ohlstein EH; Elliott JD; Feuerstein GZ; Ruffolo RR
    Med Res Rev; 1996 Jul; 16(4):365-90. PubMed ID: 8798180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin receptor antagonists: a brief review.
    Moreland S
    Can J Physiol Pharmacol; 1994 Nov; 72(11):1469-71. PubMed ID: 7767895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of potent peptide agonists and antagonists for the endothelin receptors.
    Cody WL; Doherty AM
    Biopolymers; 1995; 37(2):89-104. PubMed ID: 7893949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin receptor antagonists.
    Elliott JD; Ohlstein EH; Peishoff CE; Ellens HM; Lago MA
    Pharm Biotechnol; 1998; 11():113-29. PubMed ID: 9760678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.